Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,702 | 36,338 | 45,045 | 114,185 | 0 |
| Marketable Securities | 149,641 | 55,438 | 59,271 | N/A | 0 |
| TOTAL | $222,363 | $94,064 | $105,084 | $114,243 | $0 |
| Non-Current Assets | |||||
| PPE Net | 4,543 | 3,319 | 1,313 | 1,264 | N/A |
| Other Non-Current Assets | 139 | 3,898 | 2,231 | 1,838 | 0 |
| TOTAL | $4,682 | $7,217 | $3,544 | $3,102 | $N/A |
| Total Assets | $227,045 | $101,281 | $108,628 | $117,345 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,089 | 1,688 | 1,109 | 2,166 | 0 |
| Accrued Expenses | 2,757 | 2,753 | 1,126 | 1,737 | 0 |
| TOTAL | $4,846 | $5,641 | $3,435 | $5,103 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 727 | 1,016 | 1,304 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 137,422 | 137,659 | 0 |
| TOTAL | $N/A | $727 | $138,438 | $138,963 | $N/A |
| Total Liabilities | $4,846 | $6,368 | $141,873 | $144,066 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,953 | 1,948 | 354 | N/A | N/A |
| Common Shares | 39 | 31 | 7 | 7 | 0 |
| Retained earnings | -62,978 | -48,358 | -35,803 | -27,832 | 0 |
| Other shareholders' equity | -10 | 23 | 31 | 0 | 0 |
| TOTAL | $222,199 | $94,913 | $-33,245 | $-26,721 | $0 |
| Total Liabilities And Equity | $227,045 | $101,281 | $108,628 | $117,345 | $0 |